{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-259691","form_type":"8-K","ticker":"LITS","cik":"0001262104","company_name":"Lite Strategy, Inc.","filed_at":"2022-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.942847+00:00","generated_at":"2026-06-23T04:38:43.151881+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Director Cheryl Cohen to not stand for reelection at MEI Pharma's 2023 annual meeting","bullets":["Cheryl L. Cohen informed the board she will not stand for re-election at the fiscal year 2023 annual meeting, effective when her term expires.","Her decision is not due to any disagreement with the company's operations, policies, or practices.","Following the meeting and the earlier decision by Dr. White not to stand, the board will be reduced to seven members with no immediate replacement planned.","The board is considering a successor to the audit committee after the annual meeting; no formal decision made."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-259691","json":"https://secwatch.observer/filing/0001193125-22-259691.json","markdown":"https://secwatch.observer/filing/0001193125-22-259691.md","text":"https://secwatch.observer/filing/0001193125-22-259691.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1262104/000119312522259691/0001193125-22-259691-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1262104/000119312522259691/d405808d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:38:43.151881+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"77bd7b4b98","claim":"Cheryl L. Cohen departed as Director at Lite Strategy, Inc..","evidence_excerpt":"On October 4, 2022, Cheryl L. Cohen, a member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) and member of the Audit Committee of the Board (the “Committee”), informed the Company that she has decided not to stand for reelection at the Company’s fiscal year 2023 annual meeting of stockholders (the “Annual Meeting”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1262104/000119312522259691/0001193125-22-259691-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"decided not to stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}